Schmukler J, Li T, Pincus T
Rheumatol Adv Pract. 2024; 8(2):rkae057.
PMID: 38800575
PMC: 11116827.
DOI: 10.1093/rap/rkae057.
Rodwell N, Hassett G, Bird P, Pincus T, Descallar J, Gibson K
ACR Open Rheumatol. 2023; 5(10):511-521.
PMID: 37608509
PMC: 10570671.
DOI: 10.1002/acr2.11574.
Dissanayake K, Jayasinghe C, Wanigasekara P, Dissanayake J, Sominanda A
PLoS One. 2022; 17(11):e0278285.
PMID: 36445922
PMC: 9707768.
DOI: 10.1371/journal.pone.0278285.
Chernoff D, Scott Eastman P, Hwang C, Flake 2nd D, Wang X, Kivitz A
Clin Rheumatol. 2018; 38(2):437-445.
PMID: 30159791
DOI: 10.1007/s10067-018-4276-y.
Chua R, Mecchella J, Zbehlik A
Int J Rheumatol. 2015; 2015:834070.
PMID: 26633974
PMC: 4655059.
DOI: 10.1155/2015/834070.
Evaluating patient reported outcomes in routine practice of patients with rheumatoid arthritis treated with biological disease modifying anti rheumatic drugs (b-DMARDs).
Boone N, Teeuwisse P, van der Kuy P, Janknegt R, Landewe R
Springerplus. 2015; 4:462.
PMID: 26339563
PMC: 4551679.
DOI: 10.1186/s40064-015-1247-5.
Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis.
Michaud K, Strand V, Shadick N, Degtiar I, Ford K, Michalopoulos S
Rheumatology (Oxford). 2015; 54(9):1640-9.
PMID: 25877911
PMC: 4536857.
DOI: 10.1093/rheumatology/kev023.
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.
Castrejon I, Pincus T, Soubrier M, Lin Y, Rat A, Combe B
Rheumatology (Oxford). 2013; 52(10):1890-7.
PMID: 23864169
PMC: 3775294.
DOI: 10.1093/rheumatology/ket230.
Tools for monitoring remission in rheumatoid arthritis: any will do, let's just pick one and start measuring.
Yazici Y, Simsek I
Arthritis Res Ther. 2013; 15(1):104.
PMID: 23374997
PMC: 3672754.
DOI: 10.1186/ar4139.
Usefulness of patients-reported outcomes in rheumatoid arthritis focus group.
Amaya-Amaya J, Botello-Corzo D, Calixto O, Calderon-Rojas R, Dominguez A, Cruz-Tapias P
Arthritis. 2012; 2012:935187.
PMID: 23097701
PMC: 3465872.
DOI: 10.1155/2012/935187.
Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
Singh H, Gupta V, Ray S, Kumar H, Talapatra P, Kaur M
Clin Rheumatol. 2012; 31(12):1663-9.
PMID: 22983768
DOI: 10.1007/s10067-012-2070-9.
Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients.
Curtis J, Xie F, Chen L, Muntner P, Grijalva C, Spettell C
Arthritis Care Res (Hoboken). 2012; 64(10):1480-9.
PMID: 22833479
PMC: 3687540.
DOI: 10.1002/acr.21805.
Measures of rheumatoid arthritis disease activity in Australian clinical practice.
Taylor A, Bagga H
ISRN Rheumatol. 2012; 2011:437281.
PMID: 22389794
PMC: 3263749.
DOI: 10.5402/2011/437281.
Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis.
Barton J, Criswell L, Kaiser R, Chen Y, Schillinger D
J Rheumatol. 2009; 36(12):2635-41.
PMID: 19918045
PMC: 2874463.
DOI: 10.3899/jrheum.090569.
The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.
Leeb B, Bottcher E, Brezinschek H, Czerwenka C, Herold M, Hitzelhammer H
Clin Rheumatol. 2009; 29(2):167-74.
PMID: 19904485
PMC: 2797412.
DOI: 10.1007/s10067-009-1304-y.
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen S, Hetland M
Ann Rheum Dis. 2007; 66(11):1491-6.
PMID: 17412740
PMC: 2111618.
DOI: 10.1136/ard.2006.069252.
[Activity-score based therapy in rheumatoid arthritis].
Machold K, Nell V, Aletaha D, Smolen J, Stamm T
Z Rheumatol. 2006; 65(2):124, 126-30.
PMID: 16496075
DOI: 10.1007/s00393-006-0036-5.
Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.
Pincus T, Sokka T, Chung C, Cawkwell G
Ann Rheum Dis. 2005; 65(7):878-83.
PMID: 16339290
PMC: 1798222.
DOI: 10.1136/ard.2005.044131.